In turn, Naltrexone helps control appetite, curb emotional eating, and makes it easier to stick to a healthy diet
The STEP 1 trial showed an average weight loss of 14.9% of starting body weight over 68 weeks at this dose
Read clinical review Clinical Reviews GIP/GLP-1 Dual Agonists Drug-Drug Interaction Table: Complete Prescriber Reference A comprehensive drug-drug interaction table and prescribing guide for GIP/GLP-1 dual agonists (tirzepatide class), written at MD/PharmD level with primary-source citations
They bypass strict approval processes that require extensive clinical trials to demonstrate safety, efficacy, and consistent quality
It's probably best to avoid them altogether if you're not
So the fact that adverse-event discontinuation was numerically lower than placebo does not mean taking 4 mg felt like taking nothing